PYZCHIVA 130 mg/26mL
ustekinumab-ttwe · INJECTION, SOLUTION · SANDOZ INC
No Recall History
Plain English
PYZCHIVA is a injection, solution containing ustekinumab-ttwe at 130 mg/26mL, taken intravenous. Manufactured by SANDOZ INC.
Key Facts
- Brand Name
- PYZCHIVA
- Generic Name
- ustekinumab-ttwe
- NDC Code (Product)
61314-654- Manufacturer
- SANDOZ INC
- Strength
- 130 mg/26mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA761425
- Drug Class
- Interleukin-12 Antagonist [EPC]; Interleukin-23 Antagonist [EPC]
- Marketing Start
- 02/22/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is PYZCHIVA used for?
PYZCHIVA contains ustekinumab-ttwe. It is a injection, solution taken intravenous. Consult your doctor for specific uses.
Is PYZCHIVA a controlled substance?
PYZCHIVA is not classified as a controlled substance by the DEA.
What is the generic name for PYZCHIVA?
The generic name for PYZCHIVA is ustekinumab-ttwe. There are 4 other brand versions of ustekinumab-ttwe.
What is the NDC code for PYZCHIVA 130 mg/26mL?
The NDC (National Drug Code) for PYZCHIVA 130 mg/26mL is 61314-654, listed by SANDOZ INC.